751
Views
2
CrossRef citations to date
0
Altmetric
Review

Molecular mechanism of amygdalin action in vitro: review of the latest research

&
Pages 212-218 | Received 20 Dec 2017, Accepted 12 Feb 2018, Published online: 28 Feb 2018

References

  • Savic IM, Nikolic VD, Savic-Gajic IM, et al. Optimization of technological procedure for amygdalin isolation from plum seeds (Pruni domesticae semen). Front Plant Sci 2015;28:276.
  • Chang HK, Shin MS, Yang HY, et al. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol Pharm Bull 2006;29:1597–1602.
  • Zhou C, Qian L, Ma H, et al. Enhancement of amygdalin activated with β-D-glucosidase on HepG2 cells proliferation and apoptosis. Carbohydr Polym 2012;90:516–523.
  • Cancer C, Clin AJ. Unproven methods of cancer management. Laetrile 1991;41:187–192.
  • Rauws AG, Olling, Timmerman MA. The pharmacokinetics of amygdalin. Arch Toxicol 1982;49:311–319.
  • Greenberg DM. The case against laetrile: the fraudulent cancer remedy. Cancer 1980;15:799–807.
  • Arafa HM. Possible contribution of betaglucosidase and caspases in the cytotoxicity of glufosfamide in colon cancer cells. Eur J Pharmacol 2009;616:58–63.
  • Oliver V, Viale M, Caron G, et al. Glycosylated copper(II) ionophores as prodrugs for β-glucosidase activation in targeted cancer therapy. Dalton Trans 2013;42:2023–2034.
  • Krebs ET. Jr, The nitrilosides (vitamin B17), their nature, occurrence and metabolic significance. Antineoplastics vitamin B17. J Appl Nutr 1970;22:75–86.
  • Milazzo S, Ernst E, Lejeune S, Boehm K, Horneber M. Laetrile treatment for cancer. Cochrane Database Syst 2011;11:CD005476.
  • Zhang GM, Jin BQ. Pharmacokinetics of amygdalin in rabbits. Zhongguo Yao Li Xue Bao 1986;7:460–462.
  • Jungle E, Thomas A, Rutz J, et al. Amygdalin inhibits the growth of renal cell carcinoma cells in vitro. Int J Mol Med 2016;37:526–532.
  • Speijers G. 1993. Cyanogenic glycosides. WHO Food Additives Series 30. Geneva. JECFA.
  • Carter JH, McLafferty MA, Goldman P. Role of the gastrointestinal microflora in amygdalin (laetrile)-induced cyanide toxicity. Biochem Pharmacol 1980;29:301–304.
  • Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin 2014;64:9–29.
  • Tanaka T. Role of apoptosis in the chemoprevention of cancer. J Exp Clin Med 2013;5: 89–91.
  • Lee HM, Moon A. Amygdalin regulates apoptosis and adhesion in Hs578T triple-negative breast cancer cells. Biomol Ther (Seoul) 2016;24:62–66.
  • Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol 2013;23:620–633.
  • Lazebnik YA, Kaufmann SH, Desnoyers S, et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346–347.
  • D’Amours D, Germain M, Orth K, et al. Proteolysis of poly (ADP-ribose) polymerase by caspase 3: kinetics of cleavage of mono (ADP-ribosyl)ated and DNA-bound substrates. Radiat Res 1998;150:3–10.
  • Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326–1331.
  • Ruiter GA, Zerp SF, Bartelink H, et al. Alkyl-lysopholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res 1999;59:2457–2463.
  • Cai Y, Wang JY, Liu H. Clinical observation of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in non- small cell lung cancer patients with chemotherapy failure. Asian Pac. J. Cancer Prev 2013;14:5699–5703.
  • Hashiba K, Sano M, Nio-Kobayashi J, et al. Galectin-3 contributes to luteolysis by binding to Beta 1 integrin in the bovine corpus luteum. Biol Reprod 2014;91:1–10.
  • Pang H, Lu H, Song H, et al. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer. Cancer Epidemiol 2013;37:985–992.
  • Xia H, Seeman J, Hong J, et al. Low alpha(2)beta(1) integrin function enhances the proliferation of bro- blasts from patients with idiopathic pulmonary brosis by activation of the beta-catenin path- way. Am. J. Pathol 2012;181:222–233.
  • Zhu Y, Zhang L, Zhang GD, et al. Potential mecha- nisms of benzyl isothiocyanate suppression of invasion and angiogenesis by the U87MG human glioma cell line. Asian Pac J Cancer Prev 2014;19:8225–8228.
  • Li JC, Zhu HY, Chen TX, et al. Roles of mTOR and p-mTOR in gastro- intestinal stromal tumors. Asian Pac J Cancer Prev 2013;10:5925–5928.
  • Watabe H, Furuhama T, Tani-Ishii N, et al. Mechanotransduction activates alpha(5)beta(1) integrin and PI3K/Akt signaling. Exp. Cell Res 2011;317:2642–2649.
  • Qian L, Xie B, Wang Y, et al. Amygdalin-mediated inhibition of non-small cell lung cancer cell invasion in vitro. Int J Clin Exp Pathol 2015;8:5363–5370.
  • Calderaro J, Rebouissou S, de Koning L, et al. PI3K/AKT pathway activation in bladder carcinogenesis. Int J Cancer 2014;134:1776–1784.
  • Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544–573. 2010;
  • Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374:239–249.
  • Gogolin S, Ehemann V, Becker G, et al. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. Cell Cycle 2013;12:1091–1104.
  • Maute L, Grünwald V, Weikert S, et al. Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis. J Cancer Res Clin Oncol 2014;140:823–827.
  • Najjar YG, Rini BI. Novel agents in renal carcinoma: a reality check. Ther Adv Med Oncol 2012;4:183–194.
  • Sun M, Thuret R, Abdollah F, et al. Age-adjusted incidence, mortality, and survival rates of stage specic renal cell carcinoma in North America: a trend analysis. Eur Urol 2011;59:135–141.
  • Makarevic´ J, Rutz J, Juengel E, et al. Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2. PLoS One 2014;9:e105590:
  • Chang WL, Yu CC, Chen CS, et al. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells - a critical role of Cdk1 in mitotic entry. Biochem Pharmacol 2015;94:12–21.
  • Hwang HJ, Lee HJ, Kim CJ, et al. Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-α and IL-1β mRNA expression and carrageenan-induced rat arthritis. J Microbiol Biotechnol 2008;18:1641–1647.
  • Buritova J, Chapman V, Honore P, et al. 1997. The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats. Eur J Pharmacol 1997;320:73–80.
  • Grichnik KP, D’Amico TA. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Semin Cardiothorac Vasc Anesthes 2004;8:317–334.
  • Strauss RH, Palmer KC, Hayes JA. Acute lung injury induced by cadmium aerosol. I. Evolution of alveolar cell damage. Am J Pathol 1976;84:561–578.
  • Liu S, Feng G, Wang GL, Liu GJ. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Eur J Pharmacol 2008;584:159–165.
  • Milazzo S, Lejeune S, Ernst E. Laetrile for cancer: a systematic review of the clinical evidence. Support Care Cancer 2007;15:583–595.
  • Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009;183:787–791.
  • Van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2009;32:110–116.
  • Zhang A, Pan W, Lv J, Wu H. Protective effect of amygdalin on LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways. Inflammation 2017;40:745–751.
  • Inagaki Y, Okazak I. Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007;56:284–292.
  • Luo H, Li L, Tang J, et al. Amygdalin inhibits HSC-T6 cell proliferation and fibrosis through the regulation of TGF-β/CTGF. Mol Cell Toxicol 2016;12:265–271.
  • Cao L, Deng CQ. Effects of glycosides components and combinations of Buyang Huanwu decoction on vascular smooth muscle cells proliferation and related signaling pathway. Zhongguo Zhong Yao Za Zhi 2016;41:1889–1897.
  • Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997;350:607–614.
  • Rodino Klapac LR, Haidet AM, Kota J, et al. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 2009;39:283–296.
  • Whittemore LA, Song K, Li X, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003;300:965–971.
  • Rong J, Tilton R, Shen J, et al. Genome-wide biological response fingerprinting (BioReF) of the Chinese botanical formulation ISF-1 enables the selection of multiple marker genes as a potential metric for quality control. J Ethnopharmacol 2007;113:35–44.
  • Yang C, Li X, Yang JR, et al. Amygdalin isolated from Semen Persicae (Tao Ren) extracts induces the expression of follistatin in HepG2 and C2C12 cell lines. Chinese Med 2014;9:2–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.